Bone research strengthened in lead up to World Osteoporosis Day

October 19, 2006

As many as 100,000 Australians could be carrying a genetic mutation that predisposes them to low bone density and a higher risk of bone fractures.

Bone researchers at Griffith University are now in a position to further advance knowledge of such mutations following the announcement this week of a substantial funding win from the National Health and Medical Research Council.

World Osteoporosis Day is tomorrow (Friday, October 20).

Chief investigator Dr Nigel Morrison from Griffith's Genomics Research Centre said the RUNX2 gene was a master regulator that controlled the development of bone cells or osteoblasts.

Animal studies have confirmed that the gene is critical to bone development, and there are known mutations in humans that can cause extremely rare but severe bone disease.

"However, what we are particularly interested in, is understanding the variants of the gene that impact on more common diseases such as osteoporosis," Dr Morrison said.

"This gene is also expressed in cartilage and it may be that gene variants also have effects on conditions such as osteoarthritis."

Both diseases are complex disorders influenced by a combination of genetic and environmental factors. They are also costly diseases that contribute significantly to the burden of disease and disability in Australia.

Dr Morrison said the project would bring together an Australia-wide collaboration of clinical researchers and a US colleague who is a world leader in the functional analysis of bone genes.

"We want to understand the molecular mechanisms that control cell fate in bone - why stem cells, for example, differentiate into bone cells. To do that we will access information and DNA from extensive clinical databases."

Dr Morrison said most carriers of the RUNX2 gene variants were otherwise healthy people whose bone mineral density would be in the lower part of the normal range.

Research Australia

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to